Blood Cell Crashes After CAR-T Therapy Follow a Predictable Risk Score, Study Finds
A retrospective cohort study of 96 patients shows the CAR-HEMATOTOX score predicts severe neutropenia and thrombocytopenia after CAR-T cell therapy, ...
A retrospective cohort study of 96 patients shows the CAR-HEMATOTOX score predicts severe neutropenia and thrombocytopenia after CAR-T cell therapy, ...
A multi-stakeholder study finds that current patient-reported outcome measures fail to capture the full side-effect burden and emotional strain of ...
A systematic review and meta-analysis of 23 studies and 547 patients finds that CD19-directed CAR T-cell therapy delivers encouraging one-year ...
A Paris case report describes acute spinal cord injury after CAR T cell therapy, likely a rare spinal manifestation of ...
A comprehensive new review maps how clinicians are taming cytokine release syndrome, the most dangerous side effect of CAR T-cell ...
The randomized Phase 2 DeLLphi-309 study found that extended-interval tarlatamab dosing every three or four weeks produced efficacy, safety and ...
Success! An email was just sent to confirm your subscription. Please find the email now and click 'Confirm Follow' to start subscribing.
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine